Kestra Advisory Services’s GSK GSK Stock Holding History

Kestra Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.95M	Buy	170,831 +109,456	+178%	+$5.79M	0.03%	555
2026 Q1	$3.39M	Buy	61,375 +5,797	+10%	+$314K	0.01%	997
2025 Q4	$2.73M	Buy	55,578 +5,445	+11%	+$254K	0.01%	1044
2025 Q3	$2.16M	Buy	50,133 +4,301	+9%	+$168K	0.01%	1103
2025 Q2	$1.76M	Buy	45,832 +11,636	+34%	+$445K	0.01%	1143
2025 Q1	$1.32M	Sell	34,196 -13,391	-28%	-$490K	0.01%	1213
2024 Q4	$1.61M	Sell	47,587 -114,849	-71%	-$4.13M	0.01%	1117
2024 Q3	$6.64M	Sell	162,436 -16,846	-9%	-$689K	0.04%	498
2024 Q2	$6.9M	Buy	179,282 +116,647	+186%	+$4.91M	0.04%	483
2024 Q1	$2.69M	Buy	62,635 +22,551	+56%	+$930K	0.02%	761
2023 Q4	$1.49M	Sell	40,084 -14,905	-27%	-$535K	0.01%	945
2023 Q3	$1.99M	Sell	54,989 -1,317	-2%	-$46.7K	0.02%	684
2023 Q2	$2.01M	Buy	56,306 +5,248	+10%	+$188K	0.02%	671
2023 Q1	$1.82M	Sell	51,058 -15,102	-23%	-$528K	0.02%	686
2022 Q4	$2.32M	Sell	66,160 -3,614	-5%	-$120K	0.02%	687
2022 Q3	$2.05M	Buy	69,774 +5,507	+9%	+$209K	0.02%	656
2022 Q2	$3.5M	Buy	64,267 +6,549	+11%	+$362K	0.04%	470
2022 Q1	$3.14M	Sell	57,718 -1,024	-2%	-$55.6K	0.03%	523
2021 Q4	$3.24M	Sell	58,742 -30,326	-34%	-$1.58M	0.03%	516
2021 Q3	$4.25M	Buy	89,068 +12,342	+16%	+$620K	0.04%	444
2021 Q2	$3.82M	Buy	76,726 +315	+0.4%	+$15.1K	0.04%	432
2021 Q1	$3.41M	Sell	76,411 -46,997	-38%	-$2.13M	0.04%	429
2020 Q4	$5.71M	Buy	123,408 +52,840	+75%	+$2.43M	0.07%	300
2020 Q3	$3.32M	Buy	+70,568	New	+$3.54M	0.06%	313

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Kestra Advisory Services's GSK Position: Q2 2026 in Review

Kestra Advisory Services increased its GSK (GSK) stake by 178% in Q2 2026, buying an estimated $5.79M and bringing the position to 170,831 shares worth $8.95M. The position accounts for 0.03% of the portfolio, ranked #555.

Kestra Advisory Services first reported a position in GSK in Q3 2020 and has held it in 24 quarters since. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Kestra Advisory Services held 170,831 shares of GSK worth $8.95M as of Q2 2026.
Kestra Advisory Services bought 109,456 GSK shares in Q2 2026, an estimated $5.79M.
GSK made up 0.03% of Kestra Advisory Services's portfolio in Q2 2026, its #555 holding.
Kestra Advisory Services first reported a position in GSK in Q3 2020 and has held it in 24 quarters since.
1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.